{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:56:40Z","timestamp":1775483800721,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.joms.2008.11.015","type":"journal-article","created":{"date-parts":[[2009,3,20]],"date-time":"2009-03-20T04:50:22Z","timestamp":1237524622000},"page":"850-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Bisphosphonate-Related Osteonecrosis of the Jaws: A Single-Center Study of 101 Patients"],"prefix":"10.1016","volume":"67","author":[{"given":"Towy Sorel","family":"Lazarovici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomo","family":"Taicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Elad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izhar","family":"Hardan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noam","family":"Yarom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2008.11.015_bib1","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1652::AID-CNCR15>3.0.CO;2-Z","article-title":"Overview of bisphosphonates","volume":"80","author":"Rogers","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2008.11.015_bib2","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1359\/jbmr.1999.14.9.1557","article-title":"A dose-finding study of zoledronate in hypercalcemic cancer patients","volume":"14","author":"Body","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2008.11.015_bib3","first-page":"2949","article-title":"Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases","volume":"60","author":"Boissier","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.joms.2008.11.015_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1034\/j.1600-0609.2002.02796.x","article-title":"Bisphosphonate therapy in multiple myeloma: Past, present, future","volume":"6","author":"Jantunen","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.joms.2008.11.015_bib5","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q","article-title":"Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer","volume":"74","author":"Glover","year":"1994","journal-title":"Cancer"},{"issue":"Suppl 87","key":"10.1016\/j.joms.2008.11.015_bib6","article-title":"Zoledronate in the treatment of osteolytic bone metastases","author":"Lipton","year":"1996","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.joms.2008.11.015_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/sonc.2002.37420","article-title":"The antitumor potential of bisphosphonates","volume":"29","author":"Cl\u00e9zardin","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.joms.2008.11.015_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01623652","article-title":"Rationale for the use of alendronate in osteoporosis","volume":"5","author":"Kanis","year":"1995","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joms.2008.11.015_bib9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","article-title":"Bisphosphonate osteochemonecrosis (bis-phossy jaw): Is this phossy jaw of the 21st century?","volume":"63","author":"Hellstein","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.11.015_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joms.2008.11.015_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hon.819","article-title":"Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells","volume":"25","author":"Allegra","year":"2007","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.joms.2008.11.015_bib12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaws associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.11.015_bib13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.11.015_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.11.015_bib15","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.11.015_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2008.11.015_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2257.2006.00841.x","article-title":"Osteomyelitis and necrosis of the jaw in patients treated with bisphosphonates: A comparative study focused on multiple myeloma","volume":"28","author":"Elad","year":"2006","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.joms.2008.11.015_bib18","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis: An American Academy of Oral Medicine position paper","volume":"136","author":"Migliorati","year":"2005","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2008.11.015_bib19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.joms.2007.03.006","article-title":"Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy","volume":"65","author":"Wang","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.11.015_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: An emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2008.11.015_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.11.015_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.11.015_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jcms.2007.06.008","article-title":"\u201cBis-phossy jaws\u201d\u2014High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw","volume":"36","author":"Abu-Id","year":"2008","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2008.11.015_bib24","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible association between diabetes and bisphosphonate-related jaw osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.joms.2008.11.015_bib25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1210\/jc.2007-0098","article-title":"Diabetes and the risk of osteonecrosis of the jaw","volume":"92","author":"Favus","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.joms.2008.11.015_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/pds.1229","article-title":"Prevalence of glucose metabolism abnormalities and cardiovascular co-morbidity in the US elderly adult population","volume":"15","author":"Varas-Lorenzo","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.joms.2008.11.015_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1464-5491.2005.01787.x","article-title":"Diabetes prevalence in England, 2001\u2014Estimates from an epidemiological model","volume":"23","author":"Forouhi","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.joms.2008.11.015_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1081\/JDI-56595","article-title":"Nephrotoxicity related to new therapeutic compounds","volume":"27","author":"Szeto","year":"2005","journal-title":"Ren Fail"},{"key":"10.1016\/j.joms.2008.11.015_bib29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","article-title":"Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: A single-centre experience in 303 patients","volume":"134","author":"Zervas","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.joms.2008.11.015_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0306-9877(97)90067-0","article-title":"Is avascular necrosis of the femoral head the result of inhibition of angiogenesis?","volume":"49","author":"Smith","year":"1997","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.joms.2008.11.015_bib31","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2008.11.015_bib32","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00428-007-0516-2","article-title":"Actinomycosis of the jaws\u2014Histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis","volume":"451","author":"Hansen","year":"2007","journal-title":"Virchows Arch"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027823910801817X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027823910801817X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:27:41Z","timestamp":1759508861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027823910801817X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S027823910801817X"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2008.11.015","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonate-Related Osteonecrosis of the Jaws: A Single-Center Study of 101 Patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2008.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}